April 3 (Reuters) - AbbVie ( ABBV ) on Thursday cut its
2025 adjusted profit forecast as the drugmaker expects to incur
$248 million in acquisition-related expenses.
The company expects adjusted profit in the range of $11.99
to $12.19 per share, compared with its previous forecast of
$12.12 to $12.32 per share.